title: Biochemistry and clinical activity of N-(phosphonacetyl)-L-aspartate: a review.
authors.affiliation: Investigational Drug Branch, National Cancer Institute, Bethesda, Maryland 20892.
authors.forename: J L
authors.initials: JL
authors.lastname: Grem
authors.forename: S A
authors.initials: SA
authors.lastname: King
authors.forename: P J
authors.initials: PJ
authors.lastname: O'Dwyer
authors.forename: B
authors.initials: B
authors.lastname: Leyland-Jones
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D001224:Aspartic Acid / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D004341:Drug Evaluation; D004351:Drug Resistance; D006801:Humans; D009943:Organophosphorus Compounds / Q000627:therapeutic use*; D010746:Phosphonoacetic Acid / Q000009:adverse effects / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D009943:Organophosphorus Compounds; D001224:Aspartic Acid; C013195:sparfosic acid; D010746:Phosphonoacetic Acid